Literature DB >> 11547616

Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users.

L R Metsch1, M Pereyra, T H Brewer.   

Abstract

PURPOSE: We assessed the use of HIV care among HIV-seropositive crack cocaine smokers and other active drug users in Miami-Dade County, FL.
METHODS: Personal interviews were conducted with 327 adults recruited from inner city neighborhoods. Cross-tabulations and logistic modeling were used to analyze the relationship between selected variables and use of HIV care.
RESULTS: One-third of respondents had not seen a provider for HIV-related health care in the past 12 months. Among those who had seen a provider, only 33.8% were receiving highly active antiretroviral therapy (HAART). Factors associated with utilization of HIV-related health care were age, race, having a usual source of care, health insurance, time elapsed since time of diagnosis, and reports of moderate to extreme interference of pain with daily activities. IMPLICATIONS: These findings suggest the need to develop, implement, and evaluate intervention strategies to improve use of HIV medical care among active drug users.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11547616     DOI: 10.1016/s0899-3289(01)00064-5

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  8 in total

1.  Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

Authors:  Steffanie A Strathdee; M Latka; J Campbell; P T O'Driscoll; E T Golub; F Kapadia; R A Pollini; R S Garfein; D L Thomas; H Hagan
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

2.  Caffeine Intake and Its Association with Body Composition Measures and Macronutrient Intakes in People Living with HIV in the Miami Adult Studies on HIV Cohort.

Authors:  Venkataraghavan Ramamoorthy; Adriana Campa; Muni Rubens; Sabrina S Martinez; Christina Fleetwood; Tiffanie Stewart; Juan P Liuzzi; Florence George; Hafiz Khan; Yinghui Li; Marianna Baum
Journal:  J Caffeine Adenosine Res       Date:  2018-03-01

3.  The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

Authors:  Lynn E Sullivan; Michael Botsko; Chinazo O Cunningham; Patrick G O'Connor; David Hersh; Jennifer Mitty; Paula J Lum; Richard S Schottenfeld; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.

Authors:  Chinazo O Cunningham; Nancy L Sohler; Nina A Cooperman; Karina M Berg; Alain H Litwin; Julia H Arnsten
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

5.  Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.

Authors:  Raquel B De Boni; Bryan E Shepherd; Beatriz Grinsztejn; Carina Cesar; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan
Journal:  AIDS Behav       Date:  2016-11

6.  Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.

Authors:  Claude Ann Mellins; Jennifer F Havens; Cheryl McDonnell; Carolyn Lichtenstein; Karina Uldall; Margaret Chesney; E Karina Santamaria; James Bell
Journal:  AIDS Care       Date:  2009-02

7.  mHealth Intervention to Improve Treatment Outcomes Among People With HIV Who Use Cocaine: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Yerina S Ranjit; Archana Krishnan; Debarchana Ghosh; Claire Cravero; Xin Zhou; Frederick L Altice
Journal:  JMIR Res Protoc       Date:  2022-03-07

8.  HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts.

Authors:  Marya Gwadz; Elizabeth Applegate; Charles Cleland; Noelle Regina Leonard; Hannah Wolfe; Nadim Salomon; Mindy Belkin; Marion Riedel; Angela Banfield; Lisa Sanfilippo; Andrea Wagner; Donna Mildvan
Journal:  Front Public Health       Date:  2014-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.